Clinical Trial Update: Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents [Phase 4]

View source ↗

Summary

This is a post-marketing Phase 4 clinical study evaluating fluvoxamine maleate for treating major depressive disorder in children and adolescents, which has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Luvox (Fluvoxamine)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED